ArticleOncotarget2017
New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity.
Cavan P Bailey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleOncotarget2017
Cavan P Bailey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.